AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.04 No Change ▼ 0.00 (0%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.51 No Change ▼ 0.00 (0%)
DCL 8.55 No Change ▼ 0.00 (0%)
DFML 41.44 No Change ▼ 0.00 (0%)
DGKC 86.85 No Change ▼ 0.00 (0%)
FCCL 32.28 No Change ▼ 0.00 (0%)
FFBL 64.80 No Change ▼ 0.00 (0%)
FFL 10.25 No Change ▼ 0.00 (0%)
HUBC 109.57 No Change ▼ 0.00 (0%)
HUMNL 14.68 No Change ▼ 0.00 (0%)
KEL 5.05 No Change ▼ 0.00 (0%)
KOSM 7.46 No Change ▼ 0.00 (0%)
MLCF 41.38 No Change ▼ 0.00 (0%)
NBP 60.41 No Change ▼ 0.00 (0%)
OGDC 190.10 No Change ▼ 0.00 (0%)
PAEL 27.83 No Change ▼ 0.00 (0%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.88 No Change ▼ 0.00 (0%)
PTC 16.07 No Change ▼ 0.00 (0%)
SEARL 86.00 No Change ▼ 0.00 (0%)
TELE 7.71 No Change ▼ 0.00 (0%)
TOMCL 35.41 No Change ▼ 0.00 (0%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.41 No Change ▼ 0.00 (0%)
TRG 53.29 No Change ▼ 0.00 (0%)
UNITY 26.16 No Change ▼ 0.00 (0%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 10,010 Increased By 126.5 (1.28%)
BR30 31,023 Increased By 422.5 (1.38%)
KSE100 94,192 Increased By 836.5 (0.9%)
KSE30 29,201 Increased By 270.2 (0.93%)

imageNEW YORK: Wall Street stocks Tuesday finished lower following disappointing German economic data and ahead of Wednesday's report on US retail sales.

The Dow Jones Industrial Average dipped 9.44 points (0.06 percent) to 16,560.54.

The broad-based S&P 500 dropped 3.17 (0.16 percent) to 1,933.75, while the tech-rich Nasdaq Composite Index declined 12.08 (0.27 percent) to 4,389.25.

Market sentiment was dulled by the 18.5 point fall in the ZEW German investor confidence index to 8.6 points in August, its lowest level since December 2012.

Intercept Pharmaceuticals surged 16.6 percent higher as it disclosed encouraging clinical results from a trial on an experimental liver-disease drug. Deutsche Bank said the results "firmly establishes" Intercept's treatment as a "big player" for nonalcoholic steatohepatitis.

Another biopharmaceutical company, MannKind, sank 12.3 percent one day after disclosing a worldwide licensing deal with French pharma giant Sanofi to commercialize the Afrezza insulin therapy.

Bank of America Merrill Lynch said that while Sanofi was a "very strong" partner, the structure of the deal will delay the payoff to MannKind.

Schlumberger slid 1.2 percent after saying that US and European Union sanctions on Moscow have hit its oilfield services in Russia and will slice three cents per share from earnings in the third quarter.

Women's fashion house Kate Spade plummeted 25.4 percent as the company said a tough competitive environment has forced it to slash prices. That overshadowed an increase in the company's earnings forecast.

Bond prices fell. The yield on the 10-year US Treasury rose to 2.44 percent from 2.42 percent Monday, while the 30-year advanced to 3.27 percent from 3.23 percent. Bond prices and yields move inversely.

Comments

Comments are closed.